Video Library
The Role of Regulatory Bodies in Clinical Trials
Clinical trials play an important role in developing new treatments for Alzheimer's disease. A regulatory process overseen by the FDA in the U.S. and similar agencies around the world ensures the safety and effectiveness of these trials.
The Role of Regulatory Bodies in Clinical Trials
Clinical trials play an important role in developing new treatments for Alzheimer’s disease. A regulatory process overseen by the FDA in the U.S. and similar agencies around the world ensures the safety and effectiveness of these trials.
The Basics of Clinical Trials
Discover the rigorous scientific process behind developing treatments for Alzheimer's disease. Learn about the four different types of clinical trials, each targeting unique aspects of the disease from prevention to improving quality of life. Understand the phased...
Exploring Alzheimer’s: A Conversation with Doris Molina-Henry
Doris Molina-Henry, an Assistant Professor at the USC Keck School of Medicine Alzheimer's Therapeutic Research Institute, was in conversation with broadcaster and USC alumni Angela An. Molina-Henry's work is at the forefront of Alzheimer's research, with a specific...
Working Together on Alzheimer’s Research
ATRI and ACTC study where the science is moving on Alzheimer's disease [AD] treatment and how to move it faster. ATRI conducts trials and partners with research teams around the United States. It's a network of first-in-class, best-in-class clinical trial experts who...
Biomarkers & How They Help Diagnose Dementia
Biomarkers are measurable indicators of what’s happening in your body. They can be found in blood, other body fluids, organs, and tissues, and can be used to track healthy processes, disease progression, or even responses to medication. When combined with other tests,...
Leading The Charge On Effective New Treatments For Alzheimer’s Disease
Wall Street Journal has a new video on how Biogen’s Aduhelm is the first approved treatment for early-stage Alzheimer’s patients and that it may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to...
Generous Gifts Make Alzheimer’s Disease Research Possible
ATRI – Preventing Dementia by Preventing Stroke
Wall Street Journal has a new video on how Biogen’s Aduhelm is the first approved treatment for early-stage Alzheimer’s patients and that it may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to...
ATRI World Alzheimer’s Day Event 2022
